Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 2Head and Neck Neoplasms 2Voice Disorders 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Papilloma 1Ototoxicity 1Laryngeal Neoplasms 1Hearing Loss 1Goiter 1Esophageal Neoplasms 1Deglutition Disorders 1Cystitis, Interstitial 1Arthralgia 1

Interventions

Cisplatin 35Radiotherapy 20Magnetic Resonance Spectroscopy 19Cetuximab 17Specimen Handling 15pembrolizumab 13Carboplatin 13Radiotherapy, Intensity-Modulated 12Fluorouracil 12Docetaxel 121,2-diaminocyclohexaneplatinum II citrate 10Radiation 9Platinum 9Paclitaxel 8Surgical Procedures, Operative 7Drug Therapy 6Biopsy 6Taxes 5toripalimab 4X-Rays 4Standard of Care 4Fluorodeoxyglucose F18 4Celecoxib 4(225)Ac-DOTA-c(RGDyK) 4cemiplimab 3Nutritional Status 3Laser Therapy 3Interviews as Topic 3Hydroxyurea 3130-nm albumin-bound paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Laryngeal Neoplasms × Hyaluronic Acid × Clear all
NCT04525066 2020-08-25

Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma

Nova Scotia Health Authority

Phase 2 Completed
39 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Neoplasms, Voice Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡